Literature DB >> 1721359

The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation.

J M Armitage1, F J Fricker, P Del Nido, L Cipriani, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721359      PMCID： PMC2978529     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

1.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889
  1 in total
  6 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

2.  Two-year experience with FK 506 in pediatric patients.

Authors:  A G Tzakis; J Reyes; S Todo; B Nour; R Shapiro; M Jordan; J McCauley; J Armitage; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 3.  Tacrolimus: in heart transplant recipients.

Authors:  Paul L McCormack; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

5.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

6.  Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506.

Authors:  J M Armitage; F J Fricker; G Kurland; R L Hardesty; M Michaels; S Morita; T E Starzl; S A Yousem; R Jaffe; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  1993-02       Impact factor: 5.209
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.